Mergers & Acquisitions

Found 18,659 articles

• Stryker acquires OrthoSensor

  1/5/2021

  Stryker (NYSE:SYK) announced today the acquisition of OrthoSensor, Inc., a privately held company founded in 2007 and headquartered in Dania Beach, FL. OrthoSensor, Inc., is a leader in the digital evolution of musculoskeletal care and sensor technology for total joint replacement.

• Henry Schein Acquires Majority Interest in Prism Medical Products, Enters Home Medical Supply Market

  1/5/2021

  Henry Schein, Inc., the world’s largest provider of health care solutions to office-based dental and medical practitioners, announced the acquisition of a majority ownership position in Prism Medical Products, LLC, a nationwide provider of specialty home medical supplies with a core competency in advanced wound care products.

• Schweiger Dermatology Group Announces Acquisition of Montgomery Dermatology in King of Prussia and Audubon, Pennsylvania and Dr. Joseph Newmark in Vestal, New York

  1/5/2021

  Schweiger Dermatology Group has announced that it has completed the acquisition of Montgomery Dermatology, with three office locations in King of Prussia and Audubon, Pennsylvania.

• CooperSurgical Acquires Embryo OptionsBest-in-class digital solution helps IVF clinics improve efficiency and educate patients about embryo management

  1/5/2021

  CooperSurgical, a leading provider of women’s health care solutions, has acquired Embryo Options, an established leader in cryo-storage software solutions for clinics and patients.

• Dentsply Sirona Acquires Byte®, a Leading Direct-to-Consumer, Doctor-Directed Clear Aligner Company

  1/4/2021

  DENTSPLY SIRONA Inc., and Byte, a rapidly growing clear aligner company, announced that Dentsply Sirona acquired Byte in an all-cash deal for $1.04 billion.

• Neogen acquires food quality diagnostics company

  1/4/2021

  Neogen Corporation (NASDAQ: NEOG) announced today that it has acquired Ireland -based Megazyme, Ltd. — a major supplier of analytical solutions used by quality control laboratories in the global food and beverage industries. Megazyme will continue to operate as a standalone business, and will be managed through Neogen's European op

• Leading Independent Proxy Advisory Firm ISS Recommends BridgeBio Pharma and Eidos Therapeutics Stockholders Vote “FOR” Proposed Merger

  1/4/2021

  BridgeBio Pharma, Inc. (Nasdaq: BBIO) today announced that leading proxy advisory firm Institutional Shareholder Services (“ISS”) recommends that BridgeBio stockholders and Eidos Therapeutics, Inc. (Nasdaq: EIDX) stockholders vote “FOR” BridgeBio’s proposed merger with Eidos and each of the other proposals to be considered at both companies’ virtual special meetings to be held on January 19, 2021. 

• Charles River Laboratories Acquires Distributed Bio

  1/4/2021

  Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it acquired of Distributed Bio, Inc. on December 31, 2020.

• Wize Pharma Receives Bonus BioGroup Shares from Escrow and Additional Bonus BioGroup Shares Totaling $1.3 Million

  1/4/2021

  Wize Pharma , Inc. (OTCQB: WIZP), a clinical-stage biopharmaceutical company focused on the treatment of ophthalmic disorders, today announced that, on December 29, 2020 , it has completed the transactions contemplated by the previously reported Addendum to a Share Purchase Agreement, dated November 29, 2020 (the "Addendum

• Selvita completes acquisition of Fidelta from Galapagos

  1/4/2021

  Galapagos NV and Selvita S.A. announced that the strategic transaction in which Selvita has acquired Fidelta from Galapagos has been completed.

• Sio Gene Therapies to Sell Arvelle Stake as Part of Angelini Pharma’s Acquisition of Arvelle Therapeutics

  1/4/2021

  Sio Gene Therapies Inc. (NASDAQ: SIOX), a clinical-stage company focused on developing gene therapies to radically improve the lives of patients with neurodegenerative diseases, announced today that it has agreed to sell its stake in Arvelle Therapeutics to Angelini Pharma, as part of that company’s cash acquisition of 100% of the stock of Arvelle Therapeutics for up to $960 million.

• Integra LifeSciences Completes the Sale of its Extremity Orthopedics Business to Smith+Nephew

  1/4/2021

  Integra LifeSciences Holdings Corporation, a leading global medical technology company, announced it has completed its previously announced divestiture of its Extremity Orthopedics business to Smith+Nephew.

• Hologic to Acquire SOMATEX, Leader in Biopsy Site Markers and Localization Technologies, for $64 Million

  1/4/2021

  Hologic, Inc. (Nasdaq: HOLX), an innovative medical technology company primarily focused on improving women’s health, announced today it has completed the acquisition of SOMATEX Medical Technologies GmbH, a leader in biopsy site markers and localization technologies, for approximately $64 million.

• Aesthetic Medical International Holdings Group Limited Announces Termination of Agreement to Acquire Controlling Interest in Guangdong Hanfei Investment Management Co., Ltd.

  1/4/2021

  Aesthetic Medical International Holdings Group Limited, a leading provider of aesthetic medical services in China, announced that the Company has terminated the agreement to acquire a 51% equity interest in Guangdong Hanfei Investment Management Co., Ltd., previously announced on July 14, 2020.

• Centene Signs Definitive Agreement to Acquire Magellan Health

  1/4/2021

  Acquisition will broaden and deepen Centene's whole health capabilities, while establishing a leading behavioral health platform at a critical time

• Hart Medical Equipment Acquires McLaren Home Medical Equipment

  1/1/2021

  Hart Medical Equipment is excited to announce it has acquired McLaren Home Medical Equipment, formerly known as VitalCare in Cheboygan, Gaylord, and Petoskey in northern Michigan.

• Model N Completes Acquisition of Deloitte’s Life Sciences Pricing and Contracting Solutions Business

  12/31/2020

  Model N, Inc. (NYSE: MODN), the leader in cloud revenue management solutions, today announced that it has completed its acquisition of Deloitte’s life sciences pricing and contracting solutions business and underlying technology. With the acquisition, Model N has broadened its portfolio to better serve life sciences companies

• Thermo Fisher Scientific Acquires Programmable Dye Platform Pioneer Phitonex

  12/31/2020

  Thermo Fisher Scientific, the world leader in serving science, today announced it has completed the acquisition of Phitonex, Inc., a Durham, North Carolina -based company that has pioneered a spectral dye platform for high-resolution biology applications designed to accelerate research and development in cell therapy, immuno-onco

• Clene Nanomedicine Closes Merger with Tottenham Acquisition I Limited and Provides Corporate Update

  12/30/2020

  Clene Nanomedicine, Inc. (“Clene”) (NASDAQ: CLNN), a clinical-stage biopharmaceutical company, today announced the closing of a merger with Tottenham Acquisition I Limited (“Tottenham”) and provided a corporate update.

• Medicenna Establishes At-the-Market Sales Facility

  12/30/2020

  Medicenna Therapeutics Corp. (“Medicenna” or the “Company”) (NASDAQ: MDNA, TSX: MDNA), a clinical stage immuno-oncology company, announced today that it has entered into a sales agreement with SVB Leerink acting as sales agent (the “Sales Agreement”), pursuant to which the Company may, from time to time sell, through “at-the-market” offerings on the Nasdaq Capital Market